Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 70%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 70% · prior close shown (market closed)
AC Immune SA execution reads as mixed on proprietary earnings and initiative evidence.
Why it matters: Clinical Trial Initiation.
Watch: Clinical trial failure.
4 signals not yet derived from pipeline evidence
What it means for the thesis — synthesis, not a raw event feed.
Pipeline evidence · 0d ago
Reported figures for AC Immune SA — research only, not investment advice.
Updated
What happened recently for AC Immune SA (ACIU) — events, not interpretation.
Research & analysis only — not investment advice.
Prior close
$2.49
Market cap
$253.34M
Profitable
—
Net income
—
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for AC Immune SA — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow AC Immune SA through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.